Stock Price Quote

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE3723.4529.8 (+0.81 %)
PREV CLOSE ( ) 3693.65
OPEN PRICE ( ) 3749.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29074
TODAY'S LOW / HIGH ( )3314.95 3750.00
52 WK LOW / HIGH ( )1701 4350
NSE3726.4032.45 (+0.88 %)
PREV CLOSE( ) 3693.95
OPEN PRICE ( ) 3680.00
BID PRICE (QTY) 3726.40 (188)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 997538
TODAY'S LOW / HIGH( ) 3312.15 3752.00
52 WK LOW / HIGH ( )1700 4350
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-03 1978
Management Info
Yiu Kwan Stanley Lau - Chairman Srinivas Sadu - Managing Director
Registered Office

Address Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri District,
Hyderabad,
Telangana-500043

Phone 040 3051 0999

Email gland@glandpharma.com/investor@glandpharma.com

Website www.glandpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

25Oct Gland Pharma informs about monitoring
Pursuant to Regulation 41(4) of SEBI (Issue of Capital and Disclosure Re..
23Oct Gland Pharma informs about press release
Gland Pharmahas informed that it enclosed copies of the newspaper advert..
11Oct Reliance Industries, Gland Pharma and
Reliance Industries’ (RIL) wholly owned subsidiary -- Reliance New Energ..
09Oct Gland Pharma gets USFDA’s tentative ap
Gland Pharma has received tentative approval from the United States Food..
08Oct Announcement under Regulation 30 (LOD
Product Tentative Approval : US FDA tentative approval for Sugammadex In..
MORE

Financials

in Millions
QTR Sep 21 ANNUAL 21
Net Profit3021.29970.05
Gross Profit 4007.04 13348.52
Operating Profit 4278.3814370.43
Net Sales 10804.6934628.76
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)
peergroup  3084.55 (3.91%)
M.Cap ( in Cr)52193.28
NGL Fine-Chem (BSE)
peergroup  2554.25 (4.38%)
M.Cap ( in Cr)1578.02
Venus Remedies (BSE)
peergroup  502.90 (14.73%)
M.Cap ( in Cr)672.23
Kwality Pharma (BSE)
peergroup  913.50 (5.00%)
M.Cap ( in Cr)947.87
Dr. Reddy's Lab (BSE)
peergroup  4675.45 (0.85%)
M.Cap ( in Cr)77798.93
MORE

Shareholding Pattern

PROMOTERS 58.02%
NON-INSTITUTION 19.21%
MUTUAL FUNDS/UTI 10.98%
FI/BANKS/INSURANCE 0.41%
GOVERNMENT 0%
FII 0%
MORE

Mf Holdings

MORE

About Gland Pharma Ltd.

Gland Pharma Ltd. was incorporated in the year 1978. Its today's share price is 3723.45. Its current market capitalisation stands at Rs 61176.98 Cr. In the latest quarter, company has reported Gross Sales of Rs. 34628.76 Cr and Total Income of Rs.35976.52 Cr. The company's management includes Allen Zhang, Udo Jahannes Vetter, Yifang Wu, Essaji Goolam Vahanvati, Satyanarayana Murthy Chavali, Naina Lal Kidwai, Xiaohui Guan, Dongming Li, Qiyu Chen, Srinivas Sadu, Yiu Kwan Stanley Lau, P Sampath Kumar.

It is listed on the BSE with a BSE Code of 543245 , NSE with an NSE Symbol of GLAND and ISIN of INE068V01023. It's Registered office is at Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal-malkajgiri DistrictHyderabad-500043, Telangana. Their Registrars are ACC Ltd. It's auditors are SR Batliboi & Associates LLP, SR Batliboi & Associates, LLP, Y Raghuram & Co

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS PolicyInspection
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos